AbbVie shares higher following ‘overdone' reaction to CVS move to replace top-selling arthritis drugProactive Investors • 01/04/24
AbbVie and Umoja Biopharma Announce Strategic Collaboration to Develop Novel In-Situ CAR-T Cell TherapiesPRNewsWire • 01/04/24
Abbvie shares down as CVS moves to replace top selling arthritis drug with cheaper alternativesProactive Investors • 01/04/24